436 related articles for article (PubMed ID: 32042139)
21. Amyloid cardiomyopathy.
Kristen AV
Herz; 2020 May; 45(3):267-271. PubMed ID: 32107564
[TBL] [Abstract][Full Text] [Related]
22. The Role of Molecular Imaging in the Assessment of Cardiac Amyloidosis: State-of-the-Art.
Popescu C; Burger IA
Curr Radiopharm; 2021; 14(3):228-241. PubMed ID: 32525789
[TBL] [Abstract][Full Text] [Related]
23. Utility and pitfalls of the electrocardiogram in the evaluation of cardiac amyloidosis.
Ng PLF; Lim YC; Evangelista LKM; Wong RCC; Chai P; Sia CH; Loi HY; Yeo TC; Lin W
Ann Noninvasive Electrocardiol; 2022 Jul; 27(4):e12967. PubMed ID: 35567784
[TBL] [Abstract][Full Text] [Related]
24. Echocardiographic Findings in Cardiac Amyloidosis: Inside Two-Dimensional, Doppler, and Strain Imaging.
Di Nunzio D; Recupero A; de Gregorio C; Zito C; Carerj S; Di Bella G
Curr Cardiol Rep; 2019 Feb; 21(2):7. PubMed ID: 30747298
[TBL] [Abstract][Full Text] [Related]
25. Cardiac Amyloidosis Detected on Imaging of Patients with Heart Failure.
Roginić S; Vinter O; Trbušić M; Roginić M; Ćatić Ćuti E
Am J Case Rep; 2020 Nov; 21():e926290. PubMed ID: 33175723
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in the noninvasive strategies of cardiac amyloidosis.
Zhao L; Fang Q
Heart Fail Rev; 2016 Nov; 21(6):703-721. PubMed ID: 27554493
[TBL] [Abstract][Full Text] [Related]
27. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
[TBL] [Abstract][Full Text] [Related]
28. Multimodality Imaging in the Evaluation and Management of Cardiac Amyloidosis.
Khor YM; Cuddy S; Falk RH; Dorbala S
Semin Nucl Med; 2020 Jul; 50(4):295-310. PubMed ID: 32540027
[TBL] [Abstract][Full Text] [Related]
29. Detection of cardiac amyloidosis with
Kircher M; Ihne S; Brumberg J; Morbach C; Knop S; Kortüm KM; Störk S; Buck AK; Reiter T; Bauer WR; Lapa C
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1407-1416. PubMed ID: 30798427
[TBL] [Abstract][Full Text] [Related]
30. Cardiac amyloidosis: Recent advances in the diagnosis and therapy.
Çavuşoğlu Y; Özpelit E; Çelik A; İkitimur B; Kayıkçıoğlu M; Tokgözoğlu L; Tüfekçioğlu O; Yılmaz MB
Turk Kardiyol Dern Ars; 2019 Jun; 47(Suppl 2):1-34. PubMed ID: 31364995
[TBL] [Abstract][Full Text] [Related]
31. Cardiac Amyloidosis: Presentations, Diagnostic Work-up and Collaborative Approach for Comprehensive Clinical Management.
Joury A; Gupta T; Krim SR
Curr Probl Cardiol; 2021 Oct; 46(10):100910. PubMed ID: 34175153
[TBL] [Abstract][Full Text] [Related]
32. Multimodality imaging in cardiac amyloidosis: State-of-the-art review.
Timóteo AT; Rosa SA; Brás PG; Ferreira MJV; Bettencourt N
J Clin Ultrasound; 2022 Oct; 50(8):1084-1096. PubMed ID: 36218201
[TBL] [Abstract][Full Text] [Related]
33. Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.
Bravo PE; Dorbala S
Curr Cardiol Rep; 2017 Jul; 19(7):59. PubMed ID: 28508350
[TBL] [Abstract][Full Text] [Related]
34. Imaging cardiac amyloidosis: Patient page.
Dorbala S; Falk R
J Nucl Cardiol; 2019 Feb; 26(1):217-221. PubMed ID: 30515743
[TBL] [Abstract][Full Text] [Related]
35. Cardiac amyloidosis: An underdiagnosed/underappreciated disease.
Manolis AS; Manolis AA; Manolis TA; Melita H
Eur J Intern Med; 2019 Sep; 67():1-13. PubMed ID: 31375251
[TBL] [Abstract][Full Text] [Related]
36. EXPRESS: Epidemiology, Diagnosis and Management of Cardiac Amyloidosis.
Bashir Z; Younus A; Dhillon S; Kasi A; Bukhari S
J Investig Med; 2024 Jun; ():10815589241261279. PubMed ID: 38869161
[TBL] [Abstract][Full Text] [Related]
37. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.
Perugini E; Guidalotti PL; Salvi F; Cooke RM; Pettinato C; Riva L; Leone O; Farsad M; Ciliberti P; Bacchi-Reggiani L; Fallani F; Branzi A; Rapezzi C
J Am Coll Cardiol; 2005 Sep; 46(6):1076-84. PubMed ID: 16168294
[TBL] [Abstract][Full Text] [Related]
38. Amyloid transthyretin cardiac amyloidosis: diagnosis and management.
Di Giovanni B; Gustafson D; Delgado DH
Expert Rev Cardiovasc Ther; 2019 Sep; 17(9):673-681. PubMed ID: 31478389
[No Abstract] [Full Text] [Related]
39. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.
Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945
[TBL] [Abstract][Full Text] [Related]
40. Current state of cardiac amyloidosis.
Sharma N; Howlett J
Curr Opin Cardiol; 2013 Mar; 28(2):242-8. PubMed ID: 23324855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
